Recent Updates
Recently added Catalysts
JNJ Positive Sentiment

Johnson & Johnson to Participate in the Deutsche Bank 2026 Healthcare Summit

Wednesday, September 2, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Johnson & Johnson will present at the Deutsche Bank 2026 Healthcare Summit on September 17, 2026. The management team will engage in a Fireside Chat at 12:00 p.m. Eastern Time. Investors can access a live audio webcast through the company's Investor Relations website, with an archived version available later.

Market Sentiment Analysis

POSITIVE FACTORS

  • Johnson & Johnson is actively engaging with investors.
  • Participation in a prominent healthcare summit highlights the company's commitment.
  • The event provides a platform for management to share insights.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Canagliflozin
Phase 3 · Diabetes Mellitus, Type 2

Full Press Release Details

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the Deutsche Bank 2026 Healthcare Summit on Thursday, September 17th, 2026. Management will participate in a Fireside Chat at 12:00 p.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available appr

Frequently Asked Questions

When will Johnson & Johnson present at the summit?

Johnson & Johnson will present on September 17, 2026.

What time is the Fireside Chat scheduled?

The Fireside Chat is scheduled for 12:00 p.m. Eastern Time.

Where can I access the live webcast?

The live audio webcast can be accessed on Johnson & Johnson's Investor Relations website.

Will there be a replay of the presentation?

Yes, an archived edition of the session will be available later that day.

ShareAdd on Google
Tags: JNJ Viatris Investor Conferences Healthcare Deutsche Bank Healthcare Summit Investor Relations Fireside Chat
Last updated: Sep 2, 2026

Biotech snapshot

Cash runway
$20758M liquidity · $0M/mo burn
Low dilution risk
Lead asset
CanagliflozinPhase 3
Diabetes Mellitus, Type 2 →

Catalyst track record

+34%
best trade around JNJ's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for JNJ.

See every catalyst's timing & PoA →